我们采用蝮蛇抗栓酶治疗103例高粘滞血症患者,用药前和用药1～2个疗程后经血液流变学检测分析,发现患者红细胞压积、血浆纤维蛋白原含量、红细胞电泳时间、红细胞沉降率、全血粘度和全血还原粘度均显著降低(P>0.01)。且除全血粘度、全血还原粘度外,其余各项均恢复到正常水平。证明该药具有明显解聚、抗凝、去纤、降粘和溶栓作用,是临床上一种防治血栓病及高粘滞血症较为理想的新药。 We use viper antithrombin enzyme treatment of 103 patients with hyperviscosity, medication and medication 1 to 2 after treatment by hemorheological analysis and found that patients with hematocrit, plasma fibrinogen content, erythrocyte electrophoresis time , Erythrocyte sedimentation rate, whole blood viscosity and whole blood reducing viscosity were significantly decreased (P> 0.01). In addition to the whole blood viscosity, whole blood viscosity reduction, the rest of the rest were back to normal levels. Proved that the drug has significant depolymerization, anticoagulation, defibrillating, viscosity reduction and thrombolytic effect, is a clinical prevention and treatment of thrombosis and hyperviscosity of the ideal new drug.